BR0107211A - Agente para tratar hepatite c - Google Patents

Agente para tratar hepatite c

Info

Publication number
BR0107211A
BR0107211A BR0107211-0A BR0107211A BR0107211A BR 0107211 A BR0107211 A BR 0107211A BR 0107211 A BR0107211 A BR 0107211A BR 0107211 A BR0107211 A BR 0107211A
Authority
BR
Brazil
Prior art keywords
agent
treating hepatitis
hepatitis
treating
triaziridine
Prior art date
Application number
BR0107211-0A
Other languages
English (en)
Inventor
Wassyl Nowicky
Original Assignee
Nowicky Wassili
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassili filed Critical Nowicky Wassili
Publication of BR0107211A publication Critical patent/BR0107211A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"AGENTE PARA TRATAR HEPATITE C". é divulgado o uso do produto de conversão de alcalóides de Chelidonium majer L. com triaziridina de ácido tiofosfórico para produzir um medicamento para tratar a hepatite C.
BR0107211-0A 2000-03-22 2001-03-20 Agente para tratar hepatite c BR0107211A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c
PCT/AT2001/000076 WO2001070203A2 (de) 2000-03-22 2001-03-20 Mittel zur behandlung von hepatitis c, enthaltend ukrain

Publications (1)

Publication Number Publication Date
BR0107211A true BR0107211A (pt) 2004-01-06

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107211-0A BR0107211A (pt) 2000-03-22 2001-03-20 Agente para tratar hepatite c

Country Status (17)

Country Link
JP (1) JP2003527414A (pt)
KR (1) KR20020087045A (pt)
CN (1) CN1416347A (pt)
AT (1) AT408719B (pt)
AU (1) AU2001239000A1 (pt)
BG (1) BG107088A (pt)
BR (1) BR0107211A (pt)
CA (1) CA2389173A1 (pt)
EA (1) EA200200584A1 (pt)
HR (1) HRP20020367A2 (pt)
IL (1) IL149314A0 (pt)
IS (1) IS6360A (pt)
MA (1) MA25509A1 (pt)
MX (1) MXPA02004993A (pt)
NO (1) NO20022253L (pt)
PL (1) PL365000A1 (pt)
WO (1) WO2001070203A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
CA2664935A1 (en) * 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
BG107088A (en) 2003-05-30
AU2001239000A1 (en) 2001-10-03
CA2389173A1 (en) 2001-09-27
ATA4812000A (de) 2001-07-15
PL365000A1 (en) 2004-12-27
WO2001070203A2 (de) 2001-09-27
MXPA02004993A (es) 2003-10-14
CN1416347A (zh) 2003-05-07
IL149314A0 (en) 2002-11-10
HRP20020367A2 (en) 2004-02-29
WO2001070203A3 (de) 2002-09-06
NO20022253D0 (no) 2002-05-10
AT408719B (de) 2002-02-25
NO20022253L (no) 2002-05-10
IS6360A (is) 2002-04-24
MA25509A1 (fr) 2002-07-01
EA200200584A1 (ru) 2003-06-26
JP2003527414A (ja) 2003-09-16
KR20020087045A (ko) 2002-11-21

Similar Documents

Publication Publication Date Title
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
PT1223980E (pt) Utilizacao de inibidores de csf-1
BR0111358A (pt) Compostos de tioacetamida e seu uso
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
BR0215052A (pt) Composições acaricidas e métodos
UY26256A1 (es) Amidas de ácidos carboxílicos, medicamentos que contienen estos compuestos, su utilización y su preparación
NZ516513A (en) Nitric oxide donors for inducing neurogenesis
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
BR9916114A (pt) Uso de apomorfina na fabricação de um medicamento para tratamento de disfunção erétil orgânica masculina
DE69034070D1 (de) Racemisches Huperzin A
PT1242410E (pt) Compostos novos
PT1030667E (pt) Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono
BR0107211A (pt) Agente para tratar hepatite c
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
DK421586A (da) Irreversible dopamin-beta-hydroxylaseinhibitorer
SE0004101D0 (sv) New use
MY104521A (en) Treatment of depression.
PT1294732E (pt) Compostos de rutenio (ii) para utilizacao na terapia do cancro
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
NZ511559A (en) Use of staurosporine derivatives for treating ocular neovascular diseases
AR026243A1 (es) Solucion oral de galantamina
EE200200549A (et) Jagatud doosi teraapia veresooni kahjustava aktiivsusega
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.